
Ibrunat contains Ibrutinib 140mg, a targeted cancer therapy used to treat certain blood cancers such as Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström’s Macroglobulinemia (WM).
| Generic Name | Ibrutinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Blood Cancers |
| Availability | In Stock |




As a trusted supplier of high-quality generic anticancer medicines, we provide Ibrunat (Ibrutinib 140mg) Capsules, widely prescribed for the treatment of Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström’s Macroglobulinemia (WM).
We offer safe, consistent, and timely bulk supply of oncology drugs, including Ibrutinib (Generic Imbruvica), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers worldwide. Our global distribution network spans over 80 countries across Latin America, Africa, Asia, Europe, the Middle East, and North America, covering major markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.